Blog
Musings on Anti-Xa Activity Levels
|
![]() |
Recently, there was a good article in AJHP on dealing with transitions from oral Xa inhibitors to heparin. You can read it at AJHP 2016; 73:2037-41
This has piqued a lot of my interest in this subject since we actively use novel drug levels like dabigatran, rivaroxaban, and apixaban levels. We have published on this in the past. See: http://www.ajhp.org/content/early/2017/02/21/ajhp160168
Recently, I have been seeing a lack of understanding on how to hand...
Read Full Post »2017 ISMP Antithrombotic Therapy Self-Assessment
|
![]() |
Hello all!
Excited to announce the realease of the new, 2017 ISMP Medication Safety Self-Assessment for Antithrombotic Therapy. I would strongly encourage all practitioners who work in health-systems to review these new guidelines so we can keep our patients safe. They do cover direct acting oral anticoagulants.
http://www.ismp.org/selfassessments/Antithrombotic/2017/Default.aspx
Thank you, as always, to the leadershp shown by ISMP!
Michael P. Gusleth, Phar...
Read Full Post »